Acquisition or disposition of Scilex Holding securities by Henry Ji
| SCLX Stock | 0.64 0.04 6.67% |
Slightly above 55% of Scilex Holding's investors are presently thinking to get in. The analysis of overall sentiment of trading Scilex Holding stock suggests that some investors are interested at this time. Scilex Holding's investing sentiment can be driven by a variety of factors including economic data, Scilex Holding's earnings reports, geopolitical events, and overall market trends.
Scilex |
Filed transaction by Scilex Holding Co director. Acquisition or disposition under rule 16b-3
Read at macroaxis.com
Scilex Holding Fundamental Analysis
We analyze Scilex Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scilex Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scilex Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Scilex Holding is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Scilex Holding Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Scilex Holding stock to make a market-neutral strategy. Peer analysis of Scilex Holding could also be used in its relative valuation, which is a method of valuing Scilex Holding by comparing valuation metrics with similar companies.
Peers
Scilex Holding Related Equities
| LLY | Eli Lilly | 4.55 | ||||
| ABBV | AbbVie | 2.30 | ||||
| MRK | Merck | 1.47 | ||||
| GILD | Gilead Sciences | 0.95 | ||||
| NVS | Novartis | 0.26 | ||||
| AMGN | Amgen | 0.06 | ||||
| AZN | AstraZeneca PLC | 0.06 | ||||
| BMY | Bristol Myers | 0.07 | ||||
| SNY | Sanofi ADR | 0.14 | ||||
| GSK | GlaxoSmithKline PLC | 0.38 | ||||
| BIIB | Biogen | 0.64 |
Additional Tools for Scilex Stock Analysis
When running Scilex Holding's price analysis, check to measure Scilex Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scilex Holding is operating at the current time. Most of Scilex Holding's value examination focuses on studying past and present price action to predict the probability of Scilex Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scilex Holding's price. Additionally, you may evaluate how the addition of Scilex Holding to your portfolios can decrease your overall portfolio volatility.